Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Rivaroxaban Superior to Heparin in Preventing Blood Clots After Common Orthopedic Surgeries
03/29/2020
DOAC more effective in lowering risk of post-procedure VTE without increasing bleeding risk WASHINGTON (Mar 29, 2020) - The direct oral anticoagulant rivaroxaban dramatically cut the likelihood of serious venous thromboembolism (VTE) in...
DOAC more effective in lowering risk of post-procedure VTE without increasing bleeding risk WASHINGTON (Mar 29, 2020) - The direct oral anticoagulant rivaroxaban dramatically cut the likelihood of serious venous thromboembolism (VTE) in...
DOAC more effective in lowering...
03/29/2020
Vascular Disease Management
News
VOYAGER PAD Subgroup Analysis: Clopidogrel Atop Rivaroxaban and Aspirin Shows No Added Benefit for PAD
03/29/2020
Subgroup analysis suggests concomitant use of clopidogrel may not play role after PAD revascularizations WASHINGTON (Mar 29, 2020) - The results of VOYAGER PAD found that people with peripheral artery disease (PAD) who took the blood thinner...
Subgroup analysis suggests concomitant use of clopidogrel may not play role after PAD revascularizations WASHINGTON (Mar 29, 2020) - The results of VOYAGER PAD found that people with peripheral artery disease (PAD) who took the blood thinner...
Subgroup analysis suggests...
03/29/2020
Vascular Disease Management
News
CARAVAGGIO: Oral Apixaban as Good as Dalteparin for Treating Cancer-Associated Clots
03/29/2020
No increase in the risk of major bleeding seen, including for gastrointestinal cancers WASHINGTON (Mar 29, 2020) - For people with cancer, the oral blood thinner apixaban is at least as effective as dalteparin, a low molecular weight heparin...
No increase in the risk of major bleeding seen, including for gastrointestinal cancers WASHINGTON (Mar 29, 2020) - For people with cancer, the oral blood thinner apixaban is at least as effective as dalteparin, a low molecular weight heparin...
No increase in the risk of major...
03/29/2020
Vascular Disease Management

Advertisement

News
ACC.20/WCC: Renal Denervation Effective in Patients with Untreated Hypertension
03/29/2020
No serious adverse effects seen after three months of follow-up WASHINGTON (Mar 29, 2020) - Three months after undergoing renal denervation (RDN)—a procedure that delivers energy to overactive nerves leading to the kidney to decrease their...
No serious adverse effects seen after three months of follow-up WASHINGTON (Mar 29, 2020) - Three months after undergoing renal denervation (RDN)—a procedure that delivers energy to overactive nerves leading to the kidney to decrease their...
No serious adverse effects seen...
03/29/2020
Vascular Disease Management
News
HMP`s CardioVascular Learning Network and Vascular Disease Management Share Research and Discussions Across Large Readership/Viewing Audience
03/16/2020
March 16, 2020 — As a growing number of medical conferences are being affected by COVID-19, HMP’s CardioVascular Learning Network and Vascular Disease Management are committed to providing enhanced programming to ensure that clinicians and...
March 16, 2020 — As a growing number of medical conferences are being affected by COVID-19, HMP’s CardioVascular Learning Network and Vascular Disease Management are committed to providing enhanced programming to ensure that clinicians and...
March 16, 2020 — As a growing...
03/16/2020
Vascular Disease Management
News
Reflow Medical Announces 510(k) Clearance for an Expanded Indication for the Wingman Catheter to Cross Chronic Total Occlusions (CTOs) in Peripheral Artery Disease
03/05/2020
SAN CLEMENTE, March 5, 2020 — Reflow Medical, Inc., a California-based medical device company, has announced that they have received clearance from the FDA for an expanded indication for the Wingman™ Crossing Catheter after completing the...
SAN CLEMENTE, March 5, 2020 — Reflow Medical, Inc., a California-based medical device company, has announced that they have received clearance from the FDA for an expanded indication for the Wingman™ Crossing Catheter after completing the...
SAN CLEMENTE, March 5, 2020 —...
03/05/2020
Vascular Disease Management

Advertisement

News
BD Announces Lengths Up to 300mm on Lutonix 018 Drug Coated Balloon
03/05/2020
FRANKLIN LAKES, N.J. (Mar.
FRANKLIN LAKES, N.J. (Mar.
FRANKLIN LAKES, N.J. (Mar.
03/05/2020
Vascular Disease Management
News
FDA Clears Next Generation HydroPICC from Access Vascular
03/04/2020
Access Vascular, Inc. today announced it has received FDA clearance for the second generation of its HydroPICCTM peripherally inserted central catheter (PICC), which has demonstrated a thrombus accumulation rate 30 times less than traditional...
Access Vascular, Inc. today announced it has received FDA clearance for the second generation of its HydroPICCTM peripherally inserted central catheter (PICC), which has demonstrated a thrombus accumulation rate 30 times less than traditional...
Access Vascular, Inc. today...
03/04/2020
Vascular Disease Management
News
Midterm Outcomes in Postpartum Women Following Endovenous Treatment for Acute Deep Vein Thrombosis
02/21/2020
02/21/2020
Vascular Disease Management

Advertisement

News
Ablative Solutions Announces Publication of Data from the Peregrine Post-Market Study in the Journal of the American College of Cardiology: Cardiovascular Interventions
02/20/2020
Ablative Solutions, Inc., a company pioneering new approaches for the treatment of hypertension, today announced that positive six-month results from the Peregrine Post-Market Study demonstrating the safety and efficacy of the company's...
Ablative Solutions, Inc., a company pioneering new approaches for the treatment of hypertension, today announced that positive six-month results from the Peregrine Post-Market Study demonstrating the safety and efficacy of the company's...
Ablative Solutions, Inc., a...
02/20/2020
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

Sleep and CVD
Study of Sleep in Women Shows Delaying Bedtime by Just 90 Minutes Each Night Damages Endothelial Cells
08/06/2024
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of...
08/06/2024
Cath Lab Digest
Peripheral Interventions
VentureMed Completes Enrollment of the FLEX Vessel Prep System FLEX First AV Registry For The Treatment of Arteriovenous (AV) Access Management
07/30/2024
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has...
07/30/2024
Cath Lab Digest
Peripheral Interventions
Transit Scientific’s Novel XO Cath Microcatheter Breaks New Ground in Transradial Embolic Delivery Procedure
07/30/2024
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a...
07/30/2024
Cath Lab Digest
Carotid Artery Revascularization
Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
07/30/2024
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery...
07/30/2024
Cath Lab Digest
Health Care Needs
JACC: Almost Half of U.S. Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality
07/29/2024
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S....
07/29/2024
Cath Lab Digest
Renal Denervation
First Patients Treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS) for the Treatment of Uncontrolled Hypertension With Ultrasound Renal Denervation
07/25/2024
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on...
07/25/2024
Cath Lab Digest
Ischemic Stroke
Imperative Care Announces Clinical Data from the Pivotal Imperative Trial Evaluating the Zoom Reperfusion System for the Treatment of Ischemic Stroke
07/24/2024
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all...
07/24/2024
Cath Lab Digest
LINC
News
HMP Global’s Leipzig Interventional Course (LINC) Announces 20th Anniversary Congress in January 2025
07/22/2024
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier...
07/22/2024
Vascular Disease Management
News
Life Seal Vascular Inc. Awarded Prestigious NSF SBIR Grant to Advance Innovative Endovascular Aortic Aneurysm Sac Management Technology
07/17/2024
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF...
07/17/2024
Vascular Disease Management
Ischemic Stroke
Imperative Care Announces FDA Clearance and Initial Cases of the Zoom 6F Insert Catheters, the First Insert Catheters Built for Stroke
07/17/2024
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the...
07/17/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use